The Challenges and Novel Approaches in the Nanoparticle Formulation of DPP Inhibitors
Jaganathan Saravanan1★, Sundaramoorthi Revathi1★, Paulraj Ponnaiah2★, Vitalis Ronald Eden3★★ Corresponding author
- 1Department of Pharmaceutics, School of Pharmacy, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry Campus, Puducherry, Tamil Nadu, India.
- 2Department of Biotechnology, Faculty of Medicine and Bioscience, MAHSA University, Bandar Saujana Putra, Jenjarom, Selangor Darul Ehsan, Malaysia.
- 3Department of Biotechnology, Faculty of Pharmacy, Lincoln University, Petaling Jaya, Sunway City, Malaysia.
CORRESPONDENCE
Jaganathan Saravanan
Dr. Sundaramoorthi RevathiProfessor, Department of Pharmaceutics, School of Pharmacy, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry Campus, Puducherry, INDIA.
Received: 03-01-2025; Revised: 28-01-2025; Accepted: 18-03-2025.
Volume 14, Issue 1 · pp. 18–22 · PUBLISHED Jan-Apr 2025 · DOI: 10.5530/ajbls.20251309
ABSTRACT
Drug delivery methods based on nanoparticles have shown great promise in the effective administration of medicinal drugs, such as inhibitors of Dipeptidyl Peptidase (DPP). In the treatment of type 2 diabetes, DPP inhibitors are commonly used, and their formulation as nanoparticles offers numerous advantages, such as enhanced bioavailability, controlled release, and targeted delivery. However, several challenges exist in formulating DPP inhibitors into nanoparticles, including drug stability, particle size control, and sustained release kinetics. This review article aims to discuss the challenges associated with nanoparticle formulation of DPP inhibitors and highlight recent innovative approaches to overcome these limitations.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Saravanan, J., Revathi, S., Ponnaiah, P., & Eden, V. R. (2025). The Challenges and Novel Approaches in the Nanoparticle Formulation of DPP Inhibitors. Asian Journal of Biological and Life sciences, 14(1), 18–22. https://doi.org/10.5530/ajbls.20251309
